Correlation Between Lockheed Martin and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Lockheed Martin and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lockheed Martin and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lockheed Martin and Elevation Oncology, you can compare the effects of market volatilities on Lockheed Martin and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lockheed Martin with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lockheed Martin and Elevation Oncology.
Diversification Opportunities for Lockheed Martin and Elevation Oncology
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lockheed and Elevation is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Lockheed Martin and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Lockheed Martin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lockheed Martin are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Lockheed Martin i.e., Lockheed Martin and Elevation Oncology go up and down completely randomly.
Pair Corralation between Lockheed Martin and Elevation Oncology
Considering the 90-day investment horizon Lockheed Martin is expected to under-perform the Elevation Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Lockheed Martin is 4.96 times less risky than Elevation Oncology. The stock trades about -0.23 of its potential returns per unit of risk. The Elevation Oncology is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 65.00 in Elevation Oncology on August 23, 2024 and sell it today you would lose (4.00) from holding Elevation Oncology or give up 6.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lockheed Martin vs. Elevation Oncology
Performance |
| Timeline |
| Lockheed Martin |
| Elevation Oncology |
Lockheed Martin and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lockheed Martin and Elevation Oncology
The main advantage of trading using opposite Lockheed Martin and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lockheed Martin position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Lockheed Martin vs. Northrop Grumman | Lockheed Martin vs. General Dynamics | Lockheed Martin vs. L3Harris Technologies | Lockheed Martin vs. The Boeing |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |